Syringe company plans $800 million, 650-job plant in RTP Date Published: November 19, 2020 Stamford, Conn.-based ApiJect Ltd. plans a 1 million-square-foot plant in Research Triangle Park to make billions of syringes to be…
Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul Date Published: November 9, 2020 MORRISVILLE – Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that…
Duke researchers help develop biomaterial that improves skin healing Date Published: November 9, 2020 DURHAM – Researchers at Duke University and the University of California, Los Angeles, have developed a biomaterial that significantly reduces…
Pfizer: Coronavirus vaccine proves 90% effective in early data from trial Date Published: November 9, 2020 Drugmaker Pfizer said Monday an early look at data from its coronavirus vaccine shows it is more than 90% effective…
Alzheimer’s drug from Biogen fails to win support of FDA advisory committee Date Published: November 7, 2020 An advisory committee to the US Food and Drug Administration largely concluded in a meeting on Friday that there is…
Duke-led team finds genetic marker that could boost fight against infant brain damage Date Published: November 6, 2020 DURHAM – A Duke Health-led research team has identified a key marker that will help speed effective vaccine designs for…
Durham medtech startup 410 Medical receives FDA clearance for fluid administration device Date Published: November 3, 2020 DURHAM – Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS…
Survey: 25% of women consider career change due to pandemic; 40% mull STEM Date Published: November 2, 2020 RESEARCH TRIANGLE PARK – Millions of women are considering making a career change as the pandemic drags on, citing career…
Silicon Valley VC backs Raleigh startup with ties to Joe DeSimone that’s targeting pancreatic cancer Date Published: October 30, 2020 RALEIGH – A Raleigh life science startup targeting pancreatic cancer and other diseases with what it calls a “novel” drug…